...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >ACUTE TOXICITY STUDY OF (Z)-1-BENZHYDRYL-4- CINNAMYLPIPERAZINES IN SWISS ALBINO MICE
【24h】

ACUTE TOXICITY STUDY OF (Z)-1-BENZHYDRYL-4- CINNAMYLPIPERAZINES IN SWISS ALBINO MICE

机译:瑞士白化病小鼠中(Z)-1-苯并-4-肉桂基哌嗪的急性毒性研究

获取原文

摘要

Objective: The objective was to study the acute toxicity of (Z)-1-benzhydryl-4-cinnamylpiperazine derivatives (1a-c) using Swiss Albino mice. Methods: The acute oral and dermal toxicity studies were carried out based on OECD guidelines by adopting fixed dosage method (the limit dose is 2000 mg/kg body weight of test animal in case of dermal toxicity and 5000 mg/kg in oral toxicity). Toxicity and mortality rates were studied at intervals of 6 hrs and 14 hrs after administration of test compounds for 14 days. Results: (Z)-1-benzhydryl-4-cinnamyl piperazine derivatives (1a-c) at oral treatment of 5000 mg/kg BW and dermal toxicity study of 2000 mg/kg BW did not show any pronounced toxicity indicating their potential use for therapeutic purposes. Conclusion: All compounds 1a-c did not cause any mortality or changes in general behavior of the test animals at oral treatment of 5000 mg/kg BW indicating no conspicuous toxicity at the highest dose administered.
机译:目的:研究瑞士白化病小鼠对(Z)-1-苯甲酰基-4-肉桂基哌嗪衍生物(1a-c)的急性毒性。方法:急性经口和皮肤毒性研究是根据经合组织的指导原则,采用固定剂量方法进行的(对皮肤毒性的最大剂量为试验动物体重2000 mg / kg,对口服毒性的极限剂量为5000 mg / kg)。在施用测试化合物14天后的6小时和14小时的间隔中研究毒性和死亡率。结果:口服剂量为5000 mg / kg BW的(Z)-1-苯甲酰基-4-肉桂基哌嗪衍生物(1a-c)和2000 mg / kg BW的皮肤毒性研究未显示任何明显的毒性,表明其潜在用途治疗目的。结论:口服5000 mg / kg体重时,所有化合物1a-c均未引起试验动物的任何死亡或一般行为变化,表明在最高剂量下无明显毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号